AR-inhibitor Bicalutamide in Treating Patients With TNBC

Clinical trial NCT02353988 · UNKNOWN

Trial details

NCT number: NCT02353988
Sponsor: Jinling Hospital, China
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2015-01-01
Primary completion: 2017-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.